Dr. Dipender Gill, CEO and Founder of Sequoia Genetics, will be giving a talk at the Yale University as part of the Department of Pathology Innovation and Entrepreneurship Seminar Series.
The session will focus on the drug business as an ecosystem primed for disruption through human genetics.